A density wave in quark matter is discussed at finite temperature, which occurs along with the chiral condensation, and is described by a dual standing wave in scalar and pseudo-scalar condensates on the chiral circle. The mechanism is quite similar to that for the spin density wave suggested by Overhauser, and entirely reflects many-body effects. It is found within a mean-field approximation for NJL model that the chiral condensed phase with the density wave develops at a high-density region just outside the usual chiral-transition line in phase diagram. A magnetic property of the density wave is also elucidated.
We consider the thermodynamics of chiral models in the mean-field
approximation and discuss the relevance of the (frequently omitted) fermion
vacuum loop. Within the chiral quark-meson model and its Polyakov loop extended
version, we show that the fermion vacuum fluctuations can change the order of
the phase transition in the chiral limit and strongly influence physical
observables. We compute the temperature-dependent effective potential and
baryon number susceptibilities in these models, with and without the vacuum
term, and explore the cutoff and the pion mass dependence of the
susceptibilities. Finally, in the renormalized model the divergent vacuum
contribution is removed using the dimensional regularization.Comment: 9 pages, 5 figure
We have studied a holographically dual description of superconductor in (2 + 1)-dimensions in the presence of applied magnetic field, and observed that there exists a critical value of magnetic field, below which a charged condensate can form via a second order phase transition.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.